Faculty profile

Larry Lynd

ResearcherUniversity of British Columbia

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of British Columbia directory, so their courses may be missing. Find their university profile.

Larry Lynd

Researcher

Health Sciences

University of British Columbia

Vancouver, British Columbia, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2025.
Principal investigator on 7 research grants (7 CIHR), most recently in 2023.
Supervised 5 trainees who won CIHR awards, most recently in 2023.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Genetic Counselling Cancer Genetics Newborn Screening Pediatrics Primary Care Data Linkage Disease Progression

Latest papers

Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions
Multiple Sclerosis and Related Disorders · 2025
A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors
Multiple Sclerosis and Related Disorders · 2025
Productivity Loss Associated with Disability from Migraine: A Canada-Wide Cross-Sectional Study.
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques · 2024

All 26 publications

Latest funding

The feasibility and costs of pharmacy models supporting rural and remote communities: A simulation study
CIHR · 2025 · Co-investigator
$581,400
Transforming access to medications in rural, remote, and Indigenous communities: Implementing and evaluating virtual pharmacist care and drone delivery services
CIHR · 2025 · Co-investigator
$680,852
Lipid Nanoparticle-messenger RNA (LNP-mRNA) as a versatile therapeutic platform for brain diseases
CIHR · 2024 · Co-investigator
$577,574

All 30 grants and awards

26 publications.

Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions

Sawicka KM, Feldman BM, Beyene J, Finlayson M, Guenette M, Liu K, Lynd L, Patten SB, Toulany A, Traboulsee A

Multiple Sclerosis and Related Disorders20255 citations

DOI: 10.1016/j.msard.2025.106561

A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors

Sawicka KM, Feldman BM, Banwell B, Beyene J, Cragg JJ, Bar-Or A, Finlayson M, Guenette M, Lynd L, Raufdeen F

Multiple Sclerosis and Related Disorders20251 citations

DOI: 10.1016/j.msard.2025.106816

Productivity Loss Associated with Disability from Migraine: A Canada-Wide Cross-Sectional Study.

Naik H, Tam ACT, Trenaman L, Lynd L, Zhang W

The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques2024

DOI: 10.1017/cjn.2024.337 PMID: 39494929

Health-related quality of life among women and men living with migraine: a Canada-wide cross-sectional study.

Tam ACT, Naik H, Trenaman L, Lynd L, Zhang W

The journal of headache and pain2024

DOI: 10.1186/s10194-024-01882-4 PMID: 39379822

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.

Oh J, Arbour N, Giuliani F, Guenette M, Kolind S, Lynd L, Marrie RA, Metz LM, Prat A, Schabas A, Smyth P, Tam R, Traboulsee A, Yong VW, Patten SB

Therapeutic advances in neurological disorders2024

DOI: 10.1177/17562864241273045 PMID: 39282637

Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.

Douglas CMW, Aith F, Boon W, de Neiva Borba M, Doganova L, Grunebaum S, Hagendijk R, Lynd L, Mallard A, Mohamed FA, Moors E, Oliveira CC, Paterson F, Scanga V, Soares J, Raberharisoa V, Kleinhout-Vliek T

Orphanet journal of rare diseases2022

DOI: 10.1186/s13023-022-02476-6 PMID: 36064440

Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.

Ahmadian S, Sin DD, Lynd L, Harrison M, Sadatsafavi M

Thorax2022

DOI: 10.1136/thoraxjnl-2021-217962 PMID: 34836921

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design.

Oh J, Arbour N, Giuliani F, Guenette M, Kolind S, Lynd L, Marrie RA, Metz LM, Patten SB, Prat A, Schabas A, Smyth P, Tam R, Traboulsee A, Yong VW

BMC neurology2021

DOI: 10.1186/s12883-021-02447-7 PMID: 34706670

Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD.

Johnson KM, Sadatsafavi M, Adibi A, Lynd L, Harrison M, Tavakoli H, Sin DD, Bryan S

Applied health economics and health policy2021

DOI: 10.1007/s40258-020-00616-2 PMID: 33135094

The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines

Cragg JJ, Azoulay L, Collins G, De Vera MA, Etminan M, Lalji F, Gershon AS, Guyatt G, Harrison M, Jutzeler C

Expert Opinion on Drug Safety20212 citations

DOI: 10.1080/14740338.2021.1849134

Something wrong or missing on this profile? Suggest a correction

Larry Lynd

Research

Latest papers

Latest funding

Age of multiple sclerosis symptom onset affects mental and physical health-related quality of life in opposite directions

A cross-sectional study investigating age of multiple sclerosis onset and its association with self-management knowledge and behaviors

Productivity Loss Associated with Disability from Migraine: A Canada-Wide Cross-Sectional Study.

Health-related quality of life among women and men living with migraine: a Canada-wide cross-sectional study.

The Canadian Prospective Cohort Study to understand progression in multiple sclerosis: baseline characteristics.

Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases.

Benefit-harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease.

The Canadian prospective cohort study to understand progression in multiple sclerosis (CanProCo): rationale, aims, and study design.

Cost Effectiveness of Case Detection Strategies for the Early Detection of COPD.

The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines

Frequent collaborators

Mohsen Sadatsafavi

Carlo Marra

Jiwon Oh

Anthony Traboulsee

Mark Harrison

Wei Zhang

Stirling Bryan

Fabrizio Giuliani

Nathalie Arbour

Alene Toulany

Shannon Kolind

Alexandre Prat

Marcia Finlayson

Penelope Smyth

Joseph Beyene

Najib Ayas

Fernanda Almeida

Rosemin Kassam

Laurent Azoulay

Kuan Liu

Tetyana Kendzerska

Dawn Stacey

Gordon Guyatt

Laurent Azoulay

Helen Tremlett

Fawziah Lalji

Mahyar Etminan